Effect of antenatal corticosteroid and antibiotics in pregnancies complicated by premature rupture of membranes between 24 and 28 weeks of gestation.
The aim of this study was to assess the effectiveness of active intervention with antenatal maternal corticosteroid and antibiotics therapy in infants delivered between 24 and 28 weeks of gestation after premature rupture of membrane. This retrospective study included pregnant women complicated by preterm delivery at the Dong-A University Hospital from 1998 to 2002. Patients were divided into labor induction group 1 (n=20), observation group 2 (n=19), and medication group 3 (n=20). We evaluated the effects of prolongation of pregnancy and intervention with maternal corticosteroids and antibiotics therapy on perinatal and neonatal outcomes. Each group did not have a significant difference (p<0.05) in neonatal outcomes, such as respiratory distress syndrome, intraventricular hemorrhage, necrotizing enterocolitis, retinopathy of prematurity, pneumonia, bronchopulmonary dysplasia, and sepsis. The mean latency period was 4.7 days and 7.6 days in groups 2 and 3, respectively. Therefore, this study was unable to demonstrate any beneficial effects of corticosteroids in improving neonatal outcomes and prolongation of the latency period with antibiotics.
Song
Geun A
GA
Department of Obstetrics & Gynecology, College of Medicine, Dong-A University, Busan, Korea. root-i@hanmail.net
Han
Myoung Seok
MS
D000305:Adrenal Cortex Hormones / Q000494:pharmacology*; D000328:Adult; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001034:Apgar Score; D005260:Female; D005322:Premature Rupture of Fetal Membranes / Q000188:drug therapy*; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D008423:Maternal Age; D011247:Pregnancy; D011256:Pregnancy Outcome; D011262:Pregnancy Trimester, Second; D047928:Premature Birth / Q000517:prevention & control; D012127:Respiratory Distress Syndrome, Newborn / Q000517:prevention & control; D012189:Retrospective Studies; D013997:Time Factors
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents
Pediatrics. 1972 Oct;50(4):515-25
4561295
Am J Obstet Gynecol. 1981 Oct 1;141(3):276-87
7025638
Obstet Gynecol. 1982 Sep;60(3):277-81
7121906
Obstet Gynecol. 1988 Apr;71(4):558-62
3353046
Br J Obstet Gynaecol. 1990 Jan;97(1):11-25
2137711
Am J Obstet Gynecol. 1992 Feb;166(2):646-51
1536246
Am J Obstet Gynecol. 1992 Mar;166(3):794-802
1550145
Am J Obstet Gynecol. 1993 Oct;169(4):970-6
8238159
Am J Obstet Gynecol. 1993 Oct;169(4):976-81
8238160
Am J Obstet Gynecol. 1994 Feb;170(2):516-21
8116706
NIH Consens Statement. 1994 Feb 28-Mar 2;12(2):1-24
7728157
Am J Obstet Gynecol. 1995 Jul;173(1):322-35
7631713
Early Hum Dev. 1995 May 12;42(1):37-47
7671844
Lancet. 1995 Nov 11;346(8985):1271-9
7475723
Am J Obstet Gynecol. 1996 Feb;174(2):589-97
8623790
Obstet Gynecol. 1996 May;87(5 Pt 1):683-91
8677067
Obstet Gynecol. 1996 Nov;88(5):801-5
8885917
Am J Obstet Gynecol. 1997 May;176(5):1030-8
9166164
JAMA. 1997 Sep 24;278(12):989-95
9307346
N Engl J Med. 1998 Mar 5;338(10):663-70
9486996
Am J Obstet Gynecol. 1998 May;178(5):899-908
9609557
Obstet Gynecol. 1998 Dec;92(6):895-901
9840545
Am J Obstet Gynecol. 1999 Mar;180(3 Pt 1):677-82
10076147
Am J Obstet Gynecol. 1993 Feb;168(2):503-7
8438918
J Pediatr. 1978 Apr;92(4):529-34
305471
Pediatrics. 1979 Jan;63(1):64-72
375171
Pediatrics. 1979 Jan;63(1):73-9
375172
Lancet. 2001 Mar 31;357(9261):979-88
11293640
Am J Obstet Gynecol. 2003 Sep;189(3):799-802
14526317
J Endocrinol. 1969 Dec;45(4):515-23
5366112